JP2018517900A5 - - Google Patents

Download PDF

Info

Publication number
JP2018517900A5
JP2018517900A5 JP2017557438A JP2017557438A JP2018517900A5 JP 2018517900 A5 JP2018517900 A5 JP 2018517900A5 JP 2017557438 A JP2017557438 A JP 2017557438A JP 2017557438 A JP2017557438 A JP 2017557438A JP 2018517900 A5 JP2018517900 A5 JP 2018517900A5
Authority
JP
Japan
Prior art keywords
cells
medium
stem cells
tgfβ1
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017557438A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018517900A (ja
JP6797833B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/060049 external-priority patent/WO2016177805A1/en
Publication of JP2018517900A publication Critical patent/JP2018517900A/ja
Publication of JP2018517900A5 publication Critical patent/JP2018517900A5/ja
Priority to JP2020190850A priority Critical patent/JP7335222B2/ja
Application granted granted Critical
Publication of JP6797833B2 publication Critical patent/JP6797833B2/ja
Priority to JP2023132587A priority patent/JP7754893B2/ja
Priority to JP2025165654A priority patent/JP2026012704A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017557438A 2015-05-05 2016-05-04 効力検定 Active JP6797833B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2020190850A JP7335222B2 (ja) 2015-05-05 2020-11-17 効力検定
JP2023132587A JP7754893B2 (ja) 2015-05-05 2023-08-16 効力検定
JP2025165654A JP2026012704A (ja) 2015-05-05 2025-10-01 効力検定

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2015901605A AU2015901605A0 (en) 2015-05-05 Potency assay
AU2015901605 2015-05-05
PCT/EP2016/060049 WO2016177805A1 (en) 2015-05-05 2016-05-04 Potency assay

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020190850A Division JP7335222B2 (ja) 2015-05-05 2020-11-17 効力検定

Publications (3)

Publication Number Publication Date
JP2018517900A JP2018517900A (ja) 2018-07-05
JP2018517900A5 true JP2018517900A5 (https=) 2019-06-06
JP6797833B2 JP6797833B2 (ja) 2020-12-09

Family

ID=56087237

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017557438A Active JP6797833B2 (ja) 2015-05-05 2016-05-04 効力検定
JP2020190850A Active JP7335222B2 (ja) 2015-05-05 2020-11-17 効力検定
JP2023132587A Active JP7754893B2 (ja) 2015-05-05 2023-08-16 効力検定
JP2025165654A Pending JP2026012704A (ja) 2015-05-05 2025-10-01 効力検定

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2020190850A Active JP7335222B2 (ja) 2015-05-05 2020-11-17 効力検定
JP2023132587A Active JP7754893B2 (ja) 2015-05-05 2023-08-16 効力検定
JP2025165654A Pending JP2026012704A (ja) 2015-05-05 2025-10-01 効力検定

Country Status (9)

Country Link
US (3) US11795435B2 (https=)
EP (2) EP3292199B1 (https=)
JP (4) JP6797833B2 (https=)
KR (2) KR102582602B1 (https=)
CN (2) CN115141872A (https=)
AU (3) AU2016258980B2 (https=)
CA (1) CA2984987C (https=)
ES (2) ES3018944T3 (https=)
WO (1) WO2016177805A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202004680UA (en) 2017-11-22 2020-06-29 Mesoblast Int Sarl Cellular compositions and methods of treatment i
CA3112505C (en) * 2018-09-20 2023-06-20 Citospin, S.L. Method for obtaining an enriched population of functional mesenchymal stem cells, cells obtained thereof and compositions comprising the same
JP2022515916A (ja) * 2019-01-02 2022-02-22 メゾブラスト・インターナショナル・エスアーエールエル 腰痛を治療するための方法
US20230221303A1 (en) * 2020-04-20 2023-07-13 Longeveron Inc. Potency assay
KR20240101473A (ko) * 2022-12-23 2024-07-02 주식회사 강스템바이오텍 연골 분화능이 증진된 줄기세포의 선별 방법 및 이를 포함하는 세포 치료제

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089815A (en) 1951-10-11 1963-05-14 Lieb Hans Injectable pharmaceutical preparation, and a method of making same
US4593089A (en) 1980-07-30 1986-06-03 Abbott Laboratories Fluorescent polarization immunoassay utilizing substituted triazinylaminofluorescein aminoglycosides
US4751190A (en) 1985-07-22 1988-06-14 Abbott Laboratories Fluorescence polarization immunoassay and reagents for use therein
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US4983393A (en) 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
AU8200191A (en) 1990-07-09 1992-02-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The High efficiency packaging of mutant adeno-associated virus using amber suppressions
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
DE69233013T2 (de) 1991-08-20 2004-03-04 The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
DE4211351A1 (de) 1992-04-04 1993-10-07 Behringwerke Ag Verfahren zur Analyse partikelverstärkter Agglutinationsreaktionen auf Zentrifugalanalysatoren durch Bestimmung der Trübungsaufhellung
WO1994026877A1 (en) 1993-05-17 1994-11-24 The Regents Of The University Of California Ribozyme gene therapy for hiv infection and aids
US6541213B1 (en) 1996-03-29 2003-04-01 University Of Washington Microscale diffusion immunoassay
CA2244326C (en) 1997-08-11 2006-03-28 Shinichi Eda Microparticle enhanced light scattering agglutination assay and microparticle reagents therefor
US6566051B1 (en) 1999-01-15 2003-05-20 Medtox Scientific, Inc. Lateral flow test strip
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
WO2001097872A1 (en) 2000-06-22 2001-12-27 Austin Sam L Bioadhesive compositions and methods of preparation and use
US7205159B2 (en) 2001-08-20 2007-04-17 Proteome Systems Intellectual Property Pty Ltd. Diagnostic testing process and apparatus
WO2004046729A2 (en) 2002-11-21 2004-06-03 The University Of Leicester Bodily fluid markers of tissue hypoxia
CN101248171B (zh) 2005-04-12 2015-11-25 迈索布拉斯特股份有限公司 通过组织非特异性碱性磷酸酶分离成人多潜能细胞
KR100802011B1 (ko) * 2005-08-10 2008-02-12 인하대학교 산학협력단 층분리배양법을 이용한 골수에서의 중간엽 줄기세포분리방법
JP2011196840A (ja) * 2010-03-19 2011-10-06 Univ Of Tokyo 急性大動脈解離の検査方法
BE1020528A3 (fr) * 2011-10-11 2013-12-03 Bone Therapeutics Sa Utilisations du facteur de croissance et differenciation 8 (gdf 8).
SG11201509430WA (en) 2013-05-16 2015-12-30 Agency Science Tech & Res Heparan sulphates
KR20150016117A (ko) 2013-07-30 2015-02-11 코아스템(주) 인간 골수 유래 중간엽 줄기세포를 유효성분으로 포함하는 자가면역질환의 예방 또는 치료용 약제학적 조성물
CN103990181B (zh) * 2014-05-26 2015-07-08 中国人民解放军第四军医大学 一种具有诱导活性微载体-细胞复合物的制备方法及其应用

Similar Documents

Publication Publication Date Title
JP7506011B2 (ja) 心筋細胞シート
JP2018517900A5 (https=)
Wanjare et al. Perivascular cells in blood vessel regeneration
Lee et al. Hypoxic conditioned medium from human adipose-derived stem cells promotes mouse liver regeneration through JAK/STAT3 signaling
GB2432835A (en) Culturing human embryonic stem cells
CA2760768C (en) Lung tissue model
JP6738808B2 (ja) ヒト心室前駆体細胞を単離するための細胞表面マーカーとしてのJagged1/Frizzled4の使用
CN1768133A (zh) 使用islet1作为标志分离或产生干细胞
CN103261407B (zh) 用于识别和培养具有高度增殖潜能的多能间充质干细胞的方法
TWI772790B (zh) 前驅調節滋胚內層細胞及其用途
KR102280622B1 (ko) 이식용 장기의 개선
Ma et al. Analysis of differentially expressed microRNA of TNF-α-stimulated mesenchymal stem cells and exosomes from their culture supernatant
JP2012514983A5 (https=)
JP2012143229A5 (https=)
JP2016500260A5 (https=)
Davies et al. Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training
JP2025000600A (ja) ヒト臍帯間葉系幹細胞シート及びその製造方法
ES3062949T3 (en) Method for producing stem/precursor cells, by using low molecular weight compound, from cells derived from endodermal tissue or organ
Bellu et al. Isolating stem cells from skin: Designing a novel highly efficient non-enzymatic approach
TW202035682A (zh) 表現hla-g之肝先驅細胞及取得包含該等細胞之此等細胞組成物之方法與其用途
JP2008289486A5 (https=)
Salemi et al. Differentiated adipose-derived stem cells for bladder bioengineering
KR102023805B1 (ko) 케노데옥시콜산을 이용한 줄기세포 증식능 향상 방법
JP2022513475A (ja) Hla-eを発現する肝臓前駆細胞を含む細胞組成物
JP2014533495A5 (https=)